Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, HC Wainwright Analyst Says
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price objective lifted by investment analysts at HC Wainwright from $24.00 to $35.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 66.67% from the […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price objective lifted by investment analysts at HC Wainwright from $24.00 to $35.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 66.67% from the […]
